11.04
price down icon1.34%   -0.15
pre-market  プレマーケット:  11.10   0.06   +0.54%
loading

Biocryst Pharmaceuticals Inc (BCRX) 最新ニュース

pulisher
Jun 04, 2025

Transcript : BioCryst Pharmaceuticals, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 04 - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

BioCryst at Jefferies Conference: Promising Pipeline and Financial Growth - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

BioCryst at Jefferies Conference: Promising Pipeline and Financial Growth By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

BioCryst Pharmaceuticals (BCRX) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Best Momentum Stock to Buy for June 4th - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

biocryst pharmaceuticals extends cfo consulting agreement - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

BioCryst Extends Consulting Agreement with Former CFO - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

New Strong Buy Stocks for June 4th - Yahoo

Jun 04, 2025
pulisher
Jun 03, 2025

Best Momentum Stock To Buy For June 4th - Barchart.com

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst Pharmaceuticals Inc (BCRX) Shares Up 3.59% on Jun 3 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst (BCRX) Awards Restricted Stock Units to New Employees | BCRX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BCRX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst Expands Team with 7 Strategic Hires, Grants 47,250 Restricted Stock Units - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst stock soars to 52-week high, hits $11.14 By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst stock soars to 52-week high, hits $11.14 - Investing.com India

Jun 03, 2025
pulisher
Jun 02, 2025

BioCryst to Present New Data at 2025 Meeting of the European Aca - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology | BCRX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology - GlobeNewswire Inc.

Jun 02, 2025
pulisher
May 30, 2025

BioCryst (BCRX) Highlights Positive Data on Berotralstat for HAE Treatment | BCRX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

BioCryst Highlights Real-world Data Showing ORLADEYO® (berotrals - GuruFocus

May 30, 2025
pulisher
May 30, 2025

BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All Ages | BCRX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

BioCryst reports efficacy of HAE drug across age groups - Investing.com

May 30, 2025
pulisher
May 30, 2025

BioCryst Highlights Real-world Data Showing ORLADEYO® - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

BCRXBiocryst Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

May 30, 2025
pulisher
May 28, 2025

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Drugmaker targets younger patients as revenue balloons - The Business Journals

May 28, 2025
pulisher
May 28, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

May 28, 2025
pulisher
May 27, 2025

BioCryst to Present at Upcoming Investor Conferences | BCRX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BioCryst to Present at Upcoming Investor Conferences - The Manila Times

May 27, 2025
pulisher
May 27, 2025

How To Trade (BCRX) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Sells 261,127 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

May 27, 2025
pulisher
May 26, 2025

Wall Street Analysts Believe BioCryst (BCRX) Could Rally 55.81%: Here's is How to Trade - Yahoo Finance

May 26, 2025
pulisher
May 23, 2025

BioCryst Pharmaceuticals Inc (BCRX) Trading 3.62% Higher on May 22 - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Orladeyo reduces swelling rates in severe HAE: Real-world data - Angioedema News

May 22, 2025
pulisher
May 22, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Upgraded by StockNews.com to Strong-Buy Rating - Defense World

May 22, 2025
pulisher
May 21, 2025

Transcript : BioCryst Pharmaceuticals, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 03 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

D. E. Shaw & Co. Inc. Increases Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

May 21, 2025
pulisher
May 20, 2025

BioCryst's Orladeyo up for FDA review in pediatric HAE patients - MSN

May 20, 2025
pulisher
May 20, 2025

BioCryst Pharmaceuticals’ SWOT analysis: stock outlook amid Orladeyo success, pipeline progress - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Trims Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

May 19, 2025
pulisher
May 19, 2025

Ameriprise Financial Inc. Sells 51,920 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

May 19, 2025
pulisher
May 18, 2025

Best Momentum Stocks to Buy for May 9th - The Globe and Mail

May 18, 2025
pulisher
May 17, 2025

BioCryst reports ORLADEYO reduces severe HAE attack rates By Investing.com - Investing.com Nigeria

May 17, 2025
pulisher
May 17, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Cut to Buy at StockNews.com - Defense World

May 17, 2025
pulisher
May 16, 2025

(BCRX) Long Term Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

BioCryst reports ORLADEYO reduces severe HAE attack rates - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

BioCryst Presents New Real-world Evidence Showing Significant an - GuruFocus

May 16, 2025
pulisher
May 16, 2025

BioCryst (BCRX) Highlights Significant HAE Attack Reductions with ORLADEYO | BCRX Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat) - GlobeNewswire

May 16, 2025
pulisher
May 16, 2025

New Clinical Evidence: ORLADEYO Dramatically Reduces HAE Attacks in Both Teens and Severe Patients - Stock Titan

May 16, 2025
pulisher
May 15, 2025

FDA to review Orladeyo application for young children with HAE - Angioedema News

May 15, 2025
pulisher
May 15, 2025

FDA awards BioCryst’s Orladeyo NDA for paediatric HAE - Yahoo

May 15, 2025
pulisher
May 15, 2025

The Manufacturers Life Insurance Company Sells 195,621 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

May 15, 2025
pulisher
May 14, 2025

BioCryst (BCRX) Gains FDA Priority Review for Pediatric ORLADEYO - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside's Wet AMD Drug Advances to Phase 3: FDA Green Light Could Transform Eye Disease Treatment - Stock Titan

May 14, 2025
pulisher
May 14, 2025

FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years - Contemporary Pediatrics

May 14, 2025
pulisher
May 14, 2025

INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients - Contemporary Pediatrics

May 14, 2025
$8.59
price down icon 1.38%
drug_manufacturers_specialty_generic RDY
$14.75
price up icon 0.61%
$124.52
price down icon 0.38%
drug_manufacturers_specialty_generic HCM
$15.30
price up icon 4.08%
$323.97
price down icon 0.07%
$17.52
price up icon 1.92%
大文字化:     |  ボリューム (24 時間):